25x-NBOH
 |
This article is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it. |
25x-NBOH refers to the general form of the NBOH series of psychedelic phenethylamines. It is closely related to the better known 25x-NBOMe series.
The members of the 25x-NBOH series are generally slightly less potent and have a shorter duration than their NBOMe counterparts. Anecdotal evidence suggests minor differences in the physical and subjective effects between the two series.
For example, members of the 25x-NBOH are reportedly more favorable than their NBOMe counterpart in terms of their appreciable body-load. This may be due to the possibility that they are less well absorbed, as they otherwise have similar binding affinities.[citation needed]
The series has little or no history of human use prior to 2012 when NBOMe analogs became available for purchase from online research chemical vendors.
List of 25x-NBOH compounds
| Compound | R4 | Structure |
|---|---|---|
| 25B-NBOH | Br | 
|
| 25C-NBOH | Cl | 
|
| 25D-NBOH | CH3 | 
|
| 25I-NBOH | I | 
|
Legality
- United Kingdom - The majority of synthesised 25x-NBOH substances are Class A drugs in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause.[1] Any compounds not covered by the clause are illegal to produce, supply, or import under the Psychoactive Substance Act, which came into effect on May 26th, 2016.[2]
See also
References
 |
This article does not cite enough references. You can help by adding some. |
- ↑ United Kingdom. (2014). Misuse of Drugs Act 1971 (S.I. 2014/1106). London: The Stationery Office Limited. Retrieved July 5, 2017, from http://www.legislation.gov.uk/uksi/2014/1106/made
- ↑ Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted